A natural experiment to assess how urban interventions in lower socioeconomic areas influence health behaviors: the UrbASanté study.

Environmental exposures Lifestyle behaviors Natural experiment Self-reported health Urban intervention

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
15 03 2023
Historique:
received: 08 12 2022
accepted: 07 03 2023
entrez: 16 3 2023
pubmed: 17 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Mechanisms underlying the associations between changes in the urban environment and changes in health-related outcomes are complex and their study requires specific approaches. We describe the protocol of the interdisciplinary UrbASanté study, which aims to explore how urban interventions can modify environmental exposures (built, social, and food environments; air quality; noise), health-related behaviors, and self-reported health using a natural experiment approach. The study is based on a natural experiment design using a before/after protocol with a control group to assess changes in environmental exposures, health-risk behaviors, and self-reported health outcomes of a resident adult population before and after the implementation of a time series of urban interventions in four contiguous neighborhoods in Paris (France). The changes in environmental exposures, health-related behaviors, and self-reported health outcomes of a resident adult population will be concurrently monitored in both intervention and control areas. We will develop a mixed-method framework combining substantial fieldwork with quantitative and qualitative analytical approaches. This study will make use of (i) data relating to exposures and health-related outcomes among all participants and in subsamples and (ii) interviews with residents regarding their perceptions of their neighborhoods and with key stakeholders regarding the urban change processing, and (iii) existing geodatabases and field observations to characterize the built, social, and food environments. The data collected will be analyzed with a focus on interrelationships between environmental exposures and health-related outcomes using appropriate approaches (e.g., interrupted time series, difference-in-differences method). Relying on a natural experiment approach, the research will provide new insights regarding issues such as close collaboration with urban/local stakeholders, recruitment and follow-up of participants, identification of control and intervention areas, timing of the planned urban interventions, and comparison of subjective and objective measurements. Through the collaborative work of a consortium ensuring complementarity between researchers from different disciplines and stakeholders, the UrbASanté study will provide evidence-based guidance for designing future urban planning and public health policies. This research was registered at the ClinicalTrial.gov (NCT05743257).

Sections du résumé

BACKGROUND
Mechanisms underlying the associations between changes in the urban environment and changes in health-related outcomes are complex and their study requires specific approaches. We describe the protocol of the interdisciplinary UrbASanté study, which aims to explore how urban interventions can modify environmental exposures (built, social, and food environments; air quality; noise), health-related behaviors, and self-reported health using a natural experiment approach.
METHODS
The study is based on a natural experiment design using a before/after protocol with a control group to assess changes in environmental exposures, health-risk behaviors, and self-reported health outcomes of a resident adult population before and after the implementation of a time series of urban interventions in four contiguous neighborhoods in Paris (France). The changes in environmental exposures, health-related behaviors, and self-reported health outcomes of a resident adult population will be concurrently monitored in both intervention and control areas. We will develop a mixed-method framework combining substantial fieldwork with quantitative and qualitative analytical approaches. This study will make use of (i) data relating to exposures and health-related outcomes among all participants and in subsamples and (ii) interviews with residents regarding their perceptions of their neighborhoods and with key stakeholders regarding the urban change processing, and (iii) existing geodatabases and field observations to characterize the built, social, and food environments. The data collected will be analyzed with a focus on interrelationships between environmental exposures and health-related outcomes using appropriate approaches (e.g., interrupted time series, difference-in-differences method).
DISCUSSION
Relying on a natural experiment approach, the research will provide new insights regarding issues such as close collaboration with urban/local stakeholders, recruitment and follow-up of participants, identification of control and intervention areas, timing of the planned urban interventions, and comparison of subjective and objective measurements. Through the collaborative work of a consortium ensuring complementarity between researchers from different disciplines and stakeholders, the UrbASanté study will provide evidence-based guidance for designing future urban planning and public health policies.
TRIAL REGISTRATION
This research was registered at the ClinicalTrial.gov (NCT05743257).

Identifiants

pubmed: 36922807
doi: 10.1186/s12889-023-15388-2
pii: 10.1186/s12889-023-15388-2
pmc: PMC10015725
doi:

Banques de données

ClinicalTrials.gov
['NCT05743257']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

498

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-21-CE03-0014
Organisme : I-SITE Future Université Gustave Eiffel
ID : 2021-00194 -ANR

Informations de copyright

© 2023. The Author(s).

Références

Health Res Policy Syst. 2020 May 18;18(1):48
pubmed: 32423438
J Clin Epidemiol. 2006 May;59(5):465-71
pubmed: 16632134
PLoS One. 2010 Dec 10;5(12):e14294
pubmed: 21170320
WHO Reg Publ Eur Ser. 1996;58:i-xiii, 1-161
pubmed: 8857196
Am J Prev Med. 2009 Apr;36(4 Suppl):S166-70
pubmed: 19285209
Int J Environ Res Public Health. 2018 Jan 26;15(2):
pubmed: 29373567
Obes Rev. 2016 Jan;17 Suppl 1:31-41
pubmed: 26879111
Lancet Glob Health. 2022 Jun;10(6):e919-e926
pubmed: 35561726
PLoS One. 2017 Jan 4;12(1):e0168986
pubmed: 28052086
Prev Med Rep. 2016 May 17;4:68-74
pubmed: 27413663
Eur J Nutr. 2023 Feb;62(1):363-377
pubmed: 36029328
J Epidemiol Community Health. 2006 Apr;60(4):364-72
pubmed: 16537356
Am J Epidemiol. 2005 Feb 15;161(4):389-98
pubmed: 15692083
Prev Med. 2016 Jun;87:175-182
pubmed: 26946367
Lancet Public Health. 2019 Jan;4(1):e28-e40
pubmed: 30448150
Health Place. 2016 May;39:18-25
pubmed: 26922514
J Epidemiol Community Health. 2012 Dec;66(12):1182-6
pubmed: 22577181
Lancet. 2016 Dec 10;388(10062):2912-2924
pubmed: 27671668
Diabetes Metab. 2016 Apr;42(2):112-21
pubmed: 26404651
Int J Behav Nutr Phys Act. 2015 Dec 09;12:150
pubmed: 26646510
Int J Health Geogr. 2013 Apr 10;12:19
pubmed: 23575258

Auteurs

Hélène Charreire (H)

MoISA, Univ Montpellier, CIRAD, CIHEAM-IAMM, INRAE, Institut Agro, IRD, Montpellier, France. helene.charreire@inrae.fr.
Université Paris Est-Créteil, LabUrba, Créteil, France. helene.charreire@inrae.fr.

Benoit Conti (B)

LVMT, Univ Gustave Eiffel, Ecole des Ponts, Champs-sur-Marne, France.

Lucile Bauchard (L)

LVMT, Univ Gustave Eiffel, Ecole des Ponts, Champs-sur-Marne, France.

Ndèye Aïta Cissé (NA)

LVMT, Univ Gustave Eiffel, Ecole des Ponts, Champs-sur-Marne, France.

Marlène Perignon (M)

MoISA, Univ Montpellier, CIRAD, CIHEAM-IAMM, INRAE, Institut Agro, IRD, Montpellier, France.

Pascaline Rollet (P)

MoISA, Univ Montpellier, CIRAD, CIHEAM-IAMM, INRAE, Institut Agro, IRD, Montpellier, France.

Coline Perrin (C)

Innovation, Univ Montpellier, CIRAD, INRAE, Institut Agro, Montpellier, France.

Sophie Blanchard (S)

Université Paris Est-Créteil, LabUrba, Créteil, France.

Céline Roda (C)

Université Paris Cité, Health Environmental Risk Assessment (HERA) Team, CRESS, INSERM, INRAE, Paris, France.

Thierry Feuillet (T)

Université de Caen Normandie, UMR 6266 IDEES CNRS, Caen, France.

Malika Madelin (M)

Université Paris Cité, UMR PRODIG, Paris, France.

Vincent Dupuis (V)

Sorbonne Université, UMR PHENIX, Paris, France.

Anne-Sophie Evrard (AS)

Université Lyon, Univ Gustave Eiffel, IFSTTAR, Univ Lyon 1, Umrestte, UMR-T9405, Bron, France.

Anne-Peggy Hellequin (AP)

UMR LADYSS 7533, Université de Paris Nanterre, Nanterre, France.

Isabelle Coll (I)

Université Paris Est Créteil and Université Paris Cité, CNRS, LISA, Créteil, 94010, France.

Corinne Larrue (C)

Université Paris Est-Créteil, LabUrba, Créteil, France.

Sophie Baudet-Michel (S)

Université Paris Cité, UMR Géographie-cités, Paris, France.

Gabrielle Vernouillet (G)

Direction de la Santé Publique, Service Parisien Santé Environnement, Ville de Paris, Paris, France.

Fernande Ntsame-Abegue (F)

Direction de la Voirie et des Déplacements, Agence de la mobilité, Ville de Paris, Paris, France.

Isabelle Fabre (I)

Direction de l'Urbanisme, Ville de Paris, Paris, France.

Caroline Méjean (C)

MoISA, Univ Montpellier, CIRAD, CIHEAM-IAMM, INRAE, Institut Agro, IRD, Montpellier, France.

Jean-Michel Oppert (JM)

Department of Nutrition, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne University, Paris, France.
Sorbonne Paris Nord University, INSERM U1153, INRAE U1125, CNAM, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center - University Paris Cité (CRESS), Bobigny, 93017, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH